RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Kasturi Ranganna to Cyclin-Dependent Kinase Inhibitor p21

Back to Details
This is a "connection" page, showing publications Kasturi Ranganna has written about Cyclin-Dependent Kinase Inhibitor p21.
Kasturi Ranganna
Connection Strength
0.024
Cyclin-Dependent Kinase Inhibitor p21
  1. Mathew OP, Ranganna K, Yatsu FM. Butyrate, an HDAC inhibitor, stimulates interplay between different posttranslational modifications of histone H3 and differently alters G1-specific cell cycle proteins in vascular smooth muscle cells. Biomed Pharmacother. 2010 Dec; 64(10):733-40.
    View in: PubMed
    Score: 0.024
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support